Sequential Phage Therapy Shows Promise Against Drug-Resistant Klebsiella, But Cocktail Approach Has Limitations
Researchers found that using two bacteriophages sequentially—rather than simultaneously—more effectively treats multidrug-resistant Klebsiella pneumoniae infections in laboratory and animal models. The study revealed that when phages target the same bacterial receptor, simultaneous use can actually reduce effectiveness due to competition, but giving them in the right order (Spear first, then Loop) improves outcomes. The findings suggest that phage therapy protocols need careful optimization of dosing order to overcome resistance mechanisms and could inform treatment strategies for hard-to-treat bacterial infections.
In a study combining in vitro experiments and infection models in insect larvae, researchers investigated how two Klebsiella-targeting phages (Loop and Spear) perform when used together or sequentially against a hypervirulent bacterial strain. When administered simultaneously as a 1:1 cocktail, the phages showed antagonistic effects—actually performing worse than a single phage alone—because both target the same capsular polysaccharide receptor on the bacterial surface. However, sequential dosing revealed strong order-dependence: administering Spear followed by Loop altered bacterial growth patterns and improved survival in the animal model beyond either monotherapy alone. Resistance analysis showed that bacteria developed different mutations depending on phage exposure: capsule mutations conferred resistance to both phages but reduced bacterial virulence, while Spear-specific resistance involved mutations in a gene (fkpA) encoding a periplasmic chaperone. The researchers concluded that receptor-sharing between phages can make cocktails counterproductive, but sequential, order-aware regimens may exploit resistance-virulence trade-offs while limiting emergence of multiply-resistant mutants.
What's missing
The study was conducted in vitro and in a Galleria mellonella (insect larva) infection model; translation to human clinical efficacy remains to be determined. The authors do not discuss how findings might apply to polymicrobial infections or biofilms, which are common in clinical settings. Pharmacokinetic considerations for sequential phage dosing in humans are not addressed.
What different sources said
- bioRxivCenter
Sequential Use of Two Capsule-Targeting Klebsiella Phages Reveals Order-Dependent Efficacy and Distinct Resistance Pathways in vitro and in vivo
Related
Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.
Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics
Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.
Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study
Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.